Cargando…

NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer’s Disease

Dementia has become an all-important disease because the population is aging rapidly and the cost of health care associated with dementia is ever increasing. In addition to cognitive function impairment, associated behavioral and psychological symptoms of dementia (BPSD) worsen patient’s quality of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yu-Jhen, Lin, Chieh-Hsin, Lane, Hsien-Yuan, Tsai, Guochuan E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468881/ https://www.ncbi.nlm.nih.gov/pubmed/23450042 http://dx.doi.org/10.2174/157015912803217288

Ejemplares similares

The Role of N-Methyl-D-Aspartate Receptor Neurotransmission and Precision Medicine in Behavioral and Psychological Symptoms of Dementia
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

MET and AKT Genetic Influence on Facial Emotion Perception
por: Lin, Ming-Teng, et al.
Publicado: (2012)

Precision Medicine of Sodium Benzoate for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)
por: Lin, Chieh-Hsin, et al.
Publicado: (2020)

Involvement of Cholinergic, Adrenergic, and Glutamatergic Network Modulation with Cognitive Dysfunction in Alzheimer’s Disease
por: Cheng, Yu-Jung, et al.
Publicado: (2021)

Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia: Secondary Analysis of a Randomized Clinical Trial
por: Lin, Chieh-Hsin, et al.
Publicado: (2021)

Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior
por: Basu, Alo C., et al.
Publicado: (2008)

Differential Impacts of Endogenous Antioxidants on Clinical Symptoms and Cognitive Function in Acute and Chronic Schizophrenia Patients
por: Lin, Chieh-Hsin, et al.
Publicado: (2023)

NMDA Receptors in Astrocytes: In Search for Roles in Neurotransmission and Astrocytic Homeostasis
por: Skowrońska, Katarzyna, et al.
Publicado: (2019)

Dysfunction of NMDA receptors in Alzheimer’s disease
por: Zhang, Yan, et al.
Publicado: (2016)

New Treatment Strategies of Depression: Based on Mechanisms Related to Neuroplasticity
por: Huang, Yu-Jhen, et al.
Publicado: (2017)

Relationships between Mitochondrial Dysfunction and Neurotransmission Failure in Alzheimer’s Disease
por: Wong, Kan Yin, et al.
Publicado: (2020)

The dietary constituent resveratrol suppresses nociceptive neurotransmission via the NMDA receptor
por: Takehana, Shiori, et al.
Publicado: (2017)

Polymorphism in the LASP1 gene promoter region alters cognitive functions of patients with schizophrenia
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Deep Learning with Neuroimaging and Genomics in Alzheimer’s Disease
por: Lin, Eugene, et al.
Publicado: (2021)

Single synapse evaluation of the postsynaptic NMDA receptors targeted by evoked and spontaneous neurotransmission
por: Reese, Austin L, et al.
Publicado: (2016)

Properties of Individual Hippocampal Synapses Influencing NMDA-Receptor Activation by Spontaneous Neurotransmission
por: Metzbower, Sarah R., et al.
Publicado: (2019)

Brain Stimulation in Alzheimer's Disease
por: Chang, Chun-Hung, et al.
Publicado: (2018)

Early Identification and Intervention of Schizophrenia: Insight From Hypotheses of Glutamate Dysfunction and Oxidative Stress
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Behavioral and Psychological Symptoms in Alzheimer's Disease
por: Li, Xiao-Ling, et al.
Publicado: (2014)

d-glutamate and Gut Microbiota in Alzheimer’s Disease
por: Chang, Chun-Hung, et al.
Publicado: (2020)

Implications of GABAergic Neurotransmission in Alzheimer’s Disease
por: Li, Yanfang, et al.
Publicado: (2016)

Regulation of Melatonin and Neurotransmission in Alzheimer’s Disease
por: Roy, Jaydeep, et al.
Publicado: (2021)

Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer’s Disease
por: Chang, Chun-Hung, et al.
Publicado: (2021)

Novel Therapeutic Approaches for Alzheimer’s Disease: An Updated Review
por: Yu, Tien-Wei, et al.
Publicado: (2021)

Diagnosing Alzheimer’s Disease Specifically and Sensitively With pLG72 and Cystine/Glutamate Antiporter SLC7A11 AS Blood Biomarkers
por: Lane, Hsien-Yuan, et al.
Publicado: (2022)

Combination of G72 Genetic Variation and G72 Protein Level to Detect Schizophrenia: Machine Learning Approaches
por: Lin, Eugene, et al.
Publicado: (2018)

d-Amino Acids and pLG72 in Alzheimer’s Disease and Schizophrenia
por: Cheng, Yu-Jung, et al.
Publicado: (2021)

Trough Melatonin Levels Differ between Early and Late Phases of Alzheimer Disease
por: Lin, Chieh-Hsin, et al.
Publicado: (2021)

Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer’s Disease, and Parkinson’s Disease
por: Hsu, Wen-Yu, et al.
Publicado: (2018)

GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer’s disease
por: Nava-Mesa, Mauricio O., et al.
Publicado: (2014)

Applying a bagging ensemble machine learning approach to predict functional outcome of schizophrenia with clinical symptoms and cognitive functions
por: Lin, Eugene, et al.
Publicado: (2021)

Dysfunctional dopaminergic neurotransmission in asocial BTBR mice
por: Squillace, M, et al.
Publicado: (2014)

PM401. NMDA-enhancing agents improve cognitive function of patients with schizophrenia
por: Lane, Hsien-Yuan
Publicado: (2016)

Computational Investigation of the Changing Patterns of Subtype Specific NMDA Receptor Activation during Physiological Glutamatergic Neurotransmission
por: Singh, Pallab, et al.
Publicado: (2011)

pLG72 levels increase in early phase of Alzheimer’s disease but decrease in late phase
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Endogenous antioxidants predicted outcome and increased after treatment: A benzoate dose‐finding, randomized, double‐blind, placebo‐controlled trial for Alzheimer's disease
por: Lane, Hsien‐Yuan, et al.
Publicado: (2022)

Protein kinase C mediates hypoxia-induced long-term potentiation of NMDA neurotransmission in the visual retinocollicular pathway
por: Dumanska, Hanna, et al.
Publicado: (2023)

Mechanism of Social Stress-Related Erectile Dysfunction in Mice: Impaired Parasympathetic Neurotransmission and Ketamine
por: Wu, Shu-Yu, et al.
Publicado: (2023)

Effects of turmeric on Alzheimer's disease with behavioral and psychological symptoms of dementia
por: Hishikawa, Nozomi, et al.
Publicado: (2012)

Behavioral and Psychological Symptoms Impact Clinical Competence in Alzheimer’s Disease
por: Bertrand, Elodie, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gf2k20iaugp1hp1a865vq3g1sq